Matson, A. G.
Bunting, J. P.
Kaul, A.
Smith, D. J.
Stonestreet, J.
Herd, K.
Hodgson, R. S.
Bell, S. C.
Article History
Received: 17 May 2018
Accepted: 8 April 2019
First Online: 13 June 2019
Authors’ information
: AM is a Senior Specialist Cystic Fibrosis (CF) Accredited Practising Dietitian (APD) and Credentialed Diabetes Educator (CDE). AM has worked in adult CF care for 20 years and has an interest in gastrointestinal CF complications.
: Ethical approval was obtained as indicated in methods section via TPCH Human Research and Ethics Committee approval (HREC/12/QPCH/52). Patients provided informed written consent to be included in this study.
: not applicable.
: AM received TPCH private practice trust fund support to attend / present at national CF conference. AM received salaries from Griffith University and University of Sunshine Coast for delivery of Medical Nutrition Therapy sessional lectures.DS was the Recipient of Grant Funding from Vertex Pharmaceuticals. JS and KH received TPCH private practice trust fund to finance attendance / presentation at national CF conference and funding from Vertex Pharmaceuticals to attend a Dietitian CF Interest Group Meeting. RH received Honorarium from Shire and Fresenius Kabi for expert advice and lectures. JB, AK, and SB declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.